Freelite aids the detection and monitoring of Multiple Myeloma and related diseases
Products listed here are expected to be fully registered and state approved by the NMPA for clinical use in 2020, this is subject to change, depending on any further requirements
Find out about what Freelite is, what it's results tell you and inclusion in National and International guidelines
Learn about how you can use Freelite for diagnosis, monitoring and in a renal setting
All you need to know about using Freelite in the lab
View our current kits, measuring ranges, test sizes product codes
Literature
Discover Optilite, Freelite and our other specialist immunology assays